EMAIL US: customerservice@franklinyoung.com
CALL US: (618) 724-2780 / (909) 931-5012
CALL US: (618) 724-2780 / (909) 931-5012
Back to Previous Page
ITEM#: 3042-147822120UG
MFR#: 1478221-20UG
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin
| Product Name | Description | Item# | QTY | |
|---|---|---|---|---|
Oligosaccharide System Suitability Mixture A
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-147821020UG | EA | |
Oligosaccharide System Suitability Mixture D
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issui | 3042-147824320UG | EA | |
Oligosaccharide System Suitability Mixture C
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issui | 3042-147823220UG | EA | |
Emtricitabine System Suitability Mixture B
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuin | 3042-123513915MG | EA | |
Fondaparinux sodium System Suitability Mixture B
|
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issui | 3042-128273025MG | EA |